Professor Hagit Tulchinskyleading colorectal surgeon
At the Top Ichilov Medical Center, the percentage of successfully treated patients with small intestine cancer is significantly higher than the global average. The specialists at Top Ichilov take pride in their achievements and work to improve these indicators. Intestinal tumors are removed by leading Israeli surgeons, and non-surgical treatment is conducted using the latest medications.
Treatment of Small Intestine Cancer: Best Indicators in Israel at the Top Ichilov Clinic
The preferred method for treating small intestine cancer is always surgical removal of the tumor. The mobility of the small intestine allows for effective radical surgical interventions with complete removal of the tumor within unchanged tissues. Typically, a portion of the omentum along with lymph nodes is also excised due to the high risk of affecting these lymph nodes.
During the operation, special new suturing instruments and devices are used to restore intestinal patency, significantly reducing the time of surgical assistance and minimizing intestinal trauma, thereby avoiding complications in the postoperative period. If necessary, a fragment of the intestine is removed along with the tumor, but this does not threaten the patient's condition or affect the functionality of the small intestine.
In cases where the disease is in an advanced state, with deep invasions into neighboring organs, multiple metastases, or in patients with dangerous comorbidities, resection of the intestinal segment is not performed. Such patients undergo palliative surgery with the creation of bypass anastomoses to restore intestinal patency and alleviate the patient's condition. Unaffected loops of the intestine are connected to each other, allowing contents to pass without being retained at the affected site.
At the Top Ichilov clinic, patients simultaneously undergo a course of chemotherapy along with surgical treatment. The oncological surgeons at the clinic consider their goal to be the cure of this dangerous disease, but when this is not achievable, they do everything possible to prolong and ease the patient's condition.
Send your records — an Ichilov physician will reply within 1–2 days, free of charge.
Early Diagnosis at the Top Ichilov Clinic
Although small intestine cancer is a rare disease (occurring in 2% of cancer patients), it poses a threat to patients' lives and is difficult to diagnose. Causes of cell transformation into malignant ones can include: intestinal polyposis, chronic inflammatory processes, constant contact with toxic substances, and frequent constipation. Risk factors include smoking and alcohol abuse. Men are more frequently affected, with the incidence of the disease increasing with age, particularly among retired men.
Diagnosis of small intestine pathologies is complicated due to anatomical features: length and convolutions. However, the Top Ichilov Medical Center employs a range of methods, and a comprehensive approach to determining the disease and identifying malignant tumors guarantees an accurate and reliable diagnosis. For this, the following are widely used:
- nuclear magnetic resonance imaging;
- computed tomography;
- contrast angiography (study of abdominal vessels);
- laparoscopy (endoscopic examination of the abdominal cavity), during which a biopsy of the neoplasm is performed.
Along with targeted examination of the intestine, a series of diagnostic procedures is conducted to examine all internal organs for the detection of metastases. A general and biochemical blood test of the patient is mandatory. Characteristic signs of small intestine cancer include high ESR, presence of tumor markers, and low protein levels. After obtaining the examination results, the patient is referred to the inpatient surgical department for hospitalization and further treatment.
Cost of Small Intestine Cancer Treatment
The cost of small intestine cancer treatment is individual for each specific case and greatly depends on the extent of disease spread. In any case, the cost of treatment in Israeli clinics is much more advantageous than in oncology centers in the European Union or the United States. Typically, savings can reach 25-45%. This occurs because the Israeli government provides financial support to domestic medical institutions and regulates prices for the medical services provided there.